OverviewSuggest Edit

brtxDISC (DiscImplantedStemCells) is an investigational non-surgical treatment for bulging and herniated lumbar discs that is intended for patients who have failed non-invasive procedures and face the prospect of surgery. The treatment involves culturing a patient's own stem cells and then delivering them via a proprietary medical device to the damaged region of the disc in an outpatient procedure. ThermoStem is a treatment using brown fat stem cells that is under development for metabolic disorders including diabetes and obesity. Initial preclinical research indicates that increased amounts of brown fat in the body may be responsible for additional caloric burning as well as reduced glucose and lipid levels. brtx-C Cosmetic is based on the development of a human cellular extract that has been demonstrated in in vitro skin studies to increase the production of collagen and fibronectin, which are proteins that are essential to combating the aging of skin. Potential cosmetic uses are being explored with third parties.
TypePublic
Founded1997
HQMelville, US
Websitebiorestorative.com

Latest Updates

Employees (est.) (Dec 2018)8(-11%)
Revenue (FY, 2018)$111 K(+38%)
Share Price (Apr 2020)$0
Cybersecurity ratingBMore

Key People/Management at BioRestorative Therapies

Mark Weinreb

Mark Weinreb

Chief Executive Officer, President, and Chairman
Francisco Silva

Francisco Silva

Chief Scientist & VP, R&D
Jeffrey Radov

Jeffrey Radov

Board Member
Bob Paccasassi

Bob Paccasassi

VP, Quality & Compliance
Paul Jude

Paul Jude

Board Member
Wayne Marasco

Wayne Marasco

Chairman, Scientific Advisory Board
Show more

BioRestorative Therapies Office Locations

BioRestorative Therapies has an office in Melville
Melville, US (HQ)
40 Marcus Dr
Show all (1)

BioRestorative Therapies Financials and Metrics

BioRestorative Therapies Revenue

BioRestorative Therapies's revenue was reported to be $111 k in FY, 2018
USD

Revenue (Q3, 2019)

38.0k

Net income (Q3, 2019)

(5.1m)

EBIT (Q3, 2019)

(1.8m)

Market capitalization (22-Apr-2020)

8.8k

Closing stock price (22-Apr-2020)

0.0

Cash (30-Sept-2019)

98.1k

EV

7.6m
BioRestorative Therapies's current market capitalization is $8.8 k.
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

15.6k1.7k416.0k628.9k36.4k81.0k111.0k

Revenue growth, %

24662%51%(94%)

Cost of goods sold

1.3k208.0213.8k261.5k102.0

Gross profit

14.3k1.5k202.2k367.4k36.3k
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Revenue

10.0k5.2k1.1k125.0375.0175.9k159.9k184.9k148.8k96.1k9.1k16.2k5.0k7.0k20.0k16.0k19.0k37.0k26.0k29.0k31.0k38.0k

Cost of goods sold

1.3k162.010.060.042.4k66.1k76.4k74.6k50.9k10.071.0

Gross profit

4.0k968.0115.0315.0133.6k93.8k108.5k74.1k45.2k9.1k16.1k

Gross profit Margin, %

76%86%92%84%76%59%59%50%47%100%100%
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

71.5k363.0201.1k91.8k166.6k31.8k451.7k117.5k

Accounts Receivable

93.4k6.0k38.0k29.0k

Prepaid Expenses

46.9k18.4k20.7k20.6k29.3k30.0k34.5k

Inventories

12.5k18.0k1.9k
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Cash

7.2k14.6k3.1k12.6k104.1k498.6k119.0642.0110.4k59.2k374.0k145.9k6.4k12.8k353.1k516.2k6.3k8.9k1.9k734.08.6k3.5k105.4k496.3k1.3m98.1k

Accounts Receivable

51.0k9.0k16.0k5.0k7.0k20.0k16.0k19.0k37.0k26.0k29.0k31.0k38.0k

Prepaid Expenses

58.2k49.6k8.5k34.6k25.2k53.4k52.3k47.7k9.1k18.1k30.2k32.4k34.1k28.5k22.1k14.0k21.3k22.4k24.7k19.6k17.3k35.1k50.7k122.0k42.4k64.7k

Inventories

13.8k13.8k18.0k17.9k17.8k17.4k1.9k2.5k2.5k
USDQ2, 2011

Financial Leverage

-0.2 x
Show all financial metrics

BioRestorative Therapies Cybersecurity Score

Cybersecurity ratingPremium dataset

B

84/100

SecurityScorecard logo

BioRestorative Therapies Online and Social Media Presence

Embed Graph

BioRestorative Therapies News and Updates

BioRestorative Therapies Receives Patent in Israel For Its Metabolic Program

MELVILLE, N.Y., Dec. 12, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that the Israeli Patent Office has issued BioRestorative a Notice of Allowance on its pate…

BioRestorative Therapies Receives A Second Patent in Australia For Its Metabolic Program

MELVILLE, N.Y., Oct. 23, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that the Australia Patent Office has issued a Certificate of Grant for the Company’s patent application titled…

BioRestorative Therapies Comments on Recent Promotional Activity

MELVILLE, N.Y., Sept. 13, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (OTC: BRTX), a life sciences company focused on stem cell - based therapies, is providing comment on recent promotional activity concerning its shares of common stock traded on the OTCQB market. 

BioRestorative Therapies to Present at the 22nd Annual American Society of Gene and Cell Therapy as to Data on its Platform Technology for the Treatment of Metabolic Disorders

Cell Based Therapy for the Treatment of Type 2 Diabetes, Obesity, Hyperlipidemia and Hypertension Cell Based Therapy for the Treatment of Type 2 Diabetes, Obesity, Hyperlipidemia and Hypertension

BioRestorative Therapies Announces the Creation of a Disc Advisory Committee

Jason Lipetz, MD to Chair Committee Jason Lipetz, MD to Chair Committee

BioRestorative Therapies Receives Notice of Allowance for Key Metabolic Patent in the United States

MELVILLE, N.Y., Nov. 15, 2018 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative" or the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that the United States Patent and Trademark Office has issued BioRestorative a Notice of A…
Show more

BioRestorative Therapies Blogs

BioRestorative Therapies Receives a Second Patent in Australia for Its Metabolic Program

MELVILLE, N.Y., October 23, 2019 — BioRestorative Therapies, Inc. (the “Company”) (OTC: BRTX), a life sciences company focused on stem […]

BioRestorative Therapies Scientific Advisory Board Member and Clinical Director of Regenerative Disc/Spine Program, Dr. Wayne J. Olan, to Receive Prestigious Award

MELVILLE, N.Y., September 16, 2019 — BioRestorative Therapies, Inc. (the “Company”) (OTC: BRTX), a life sciences company focused on stem […]

BioRestorative Therapies Announces New Initiative to Target Polycystic Ovarian Syndrome

MELVILLE, N.Y., September 11, 2019 — BioRestorative Therapies, Inc. (the “Company”) (OTC: BRTX), a life sciences company focused on stem […]

ASGCT Presentation April 2019

ASGCT Presentation April 2019

ASGCT Poster April 2019

ASGCT Poster 2019

BRTX-100 Overview

Show more

BioRestorative Therapies Frequently Asked Questions

  • When was BioRestorative Therapies founded?

    BioRestorative Therapies was founded in 1997.

  • Who are BioRestorative Therapies key executives?

    BioRestorative Therapies's key executives are Mark Weinreb, Francisco Silva and Jeffrey Radov.

  • How many employees does BioRestorative Therapies have?

    BioRestorative Therapies has 8 employees.

  • What is BioRestorative Therapies revenue?

    Latest BioRestorative Therapies annual revenue is $111 k.

  • What is BioRestorative Therapies revenue per employee?

    Latest BioRestorative Therapies revenue per employee is $13.9 k.

  • Who are BioRestorative Therapies competitors?

    Competitors of BioRestorative Therapies include Excel Life Sciences, BreatheAmerica and Princeton Center for Clinical Research.

  • Where is BioRestorative Therapies headquarters?

    BioRestorative Therapies headquarters is located at 40 Marcus Dr, Melville.

  • Where are BioRestorative Therapies offices?

    BioRestorative Therapies has an office in Melville.

  • How many offices does BioRestorative Therapies have?

    BioRestorative Therapies has 1 office.